Abstract
The critically ill surgical patient is at high risk for immune dysfunction. Severe stress states (such as multiple trauma and sepsis) produce a deleterious, potentially lethal, immunologic dichotomy. The uncontrolled disseminated activation of the normally protective immunoinflammatory cascades produces a “malignant systemic inflammation” that leads to diffuse multiple organ bystander injury, progressive organ dysfunction, and ultimate sequential organ failure referred to as multiple organ failure syndrome (MOFS) [1–3]. Concomitantly, this “malignant systemic inflammation” induces a simultaneous prolonged and excessive down-regulatory and ultimately immunosuppressive response. In addition, the diffuse activation of these inflammatory cascades leads to a consumptive depletion of the normal protective mechanisms of the immune system. Thus, the appropriate immunomodulation of the critically ill patient will not only prevent MOFS but also maintain normal host defense mechanisms and prevent nosocomial infections, which further induce the malignant systemic inflammatory response, and ultimate organ failure. A major challenge at present is the inability to identify the most critical abnormal components of the immunologic response present in the critically ill patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maier RV (1993) The “angry” macrophage and its impact on host response mechanisms. In: Faist E, Meakins JL, Schildberg, FW (eds) Host defense dysfunction in trauma, shock and sepsis. Springer, Berlin Heidelberg New York
Carrico CJ, Meakins JL, Maier RV et al. (1986) Multiple-organ-failure syndrome. Arch Surg 121:196–208
Goris RJA, te Boekhorst TPA, Nuytinck JKS et al. (1985) Multiple organ failure: generalized autodestructive inflammation? Arch Surg 120:1109
Henson PM, Larsen GL, Webster RO et al. (1982) Pulmonary microvascular alterations and injury induced by complement fragments: synergistic effect of complement activation, neutrophil sequestration, and prostaglandins. Ann NY Acad Sei 384:287–300
Welbourn CRB, Goldman G, Paterson IS et al. (1991) Pathophysiology of ischemia reperfusion injury: central role of the neutrophil. Br J Surg 78:651–656
Redl H, Dinges HP, Buurman WA, van der Linden CJ et al. (1991) Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic/ hypovolemic shock in the baboon. Am J Pathol (139)2:461–466
Greenman RL, Schein RMH, Martin MA et al. (1991) A controlled clinical trial of E6 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097–1102
Ziegler EJ, Fisher CJ, Sprung CL et al. (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324:429–436
Wakabayashi G, Gelfand JA, Burke JF et al. (1991) A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. EASEBJ 5:338–343
Dinarello CA (1984) Interleukin-1 and pathogenesis of the acute-phase response. N Engl J Med 311:1413–1418
Tracey KJ, Beutler B, Lowry SF et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474
Fletcher JR, Disimone AG, Earnest MA (1990) Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endo-toxemia. Ann Surg 211:312–316
Maier RV, Hahnel GB, Fletcher JR (1992) Platelet activating factor augments tumor necrosis factor and procoagulant activity. J Surg Res 52:258–264
Hershman MJ, Polk HC Jr, Pietsch JD et al. (1988) Modulation of infection by gamma interferon treatment following trauma. Infect Immun 56:2412–2416
Faist E, Mewes A, Strasser T et al. (1988) Aeteration of monocyte function following major injury. Arch Surg 123:287–292
Maier RV (1992) What’s new in surgery — critical care metabolism. Bull Am Coll Surg 77:22–26
Wilmore DW (1991) Catabolic illness: strategies for enhancing recovery. N Engl J Med 325:695–702
Cerra FB (1991) Nutrient modulation of inflammatory and immune function. Am J Surg 161:230–234
Fisher JE, Hasseigren PO (1991) Cytokines and glucocorticoids in the regulation of the “hepato-skeletal muscle axis” in sepsis. Am J Surg 6:266–271
Thompson WA, Coyle SM, Lazarus D et al. (1991) The metabolic effects of a continuous infusion of insulin-like growth factor (IGF-1) in parenterally fed men. Surg Forum 42:23–25
Hong RW, Robinson MK, Rounds JD et al. (1991) Glutamine protects the liver following corynebacterium parvum/endotoxin-induced hepatic necrosis. Surg Forum 42:1–3
Robinson MK, Hong RW, Rounds JD et al. (1991) Glutathione depletion enhances bacterial translocation and alters immunologic status. Surg Forum 42:65–67
Sato TT, Garcia IA, Maier RV (1992) Immunomodulation of cultured human monocytes by omega-3 fatty acid. Surg Forum 43:9–10
Griswold JA, Grogan JB, Metcalf J et al. (1991) The impact of dietary fish oil in endotoxin-induced stress. Surg Forum 42:9–11
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Maier, R.V. (1995). Immunomodulation in the Critically Ill Surgical Patient. In: Engemann, R., Holzheimer, R., Thiede, A. (eds) Immunology and Its Impact on Infections in Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79079-9_32
Download citation
DOI: https://doi.org/10.1007/978-3-642-79079-9_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58145-1
Online ISBN: 978-3-642-79079-9
eBook Packages: Springer Book Archive